Kleris G S, Hall S W, Hartford T J
J Am Vener Dis Assoc. 1976 Dec;3(2 Pt 1):84-6.
Penicillin has remained the choice drug for the treatment of gonorrhea. Its cure rate has been relative, and because cure rates are not as good as one would wish, an additional increase in dosage has been advised. Despite an improved cure rate with increased dosages, we are rapidly approaching a dose requirement beyond that which can be administered practically on an outpatient basis. Therefore other antimicrobial agents have been evaluated for the treatment of gonorrhea. Ampicillin 2 gm (IM) with 1 gm probenecid was evaluated in 1969 with a 99% plus cure rate. It also has been found that 3.5 gm of ampicillin orally (7 capsules of 500 mg) and probenecid (2 tablets of 500 mg) is an effective treatment for gonorrhea. We undertook the present study to evaluate the efficacy of a new single oral combination treatment, Polycillin-PRB.
青霉素一直是治疗淋病的首选药物。其治愈率相对较低,由于治愈率不尽人意,有人建议进一步增加剂量。尽管增加剂量后治愈率有所提高,但我们很快就会达到实际门诊治疗难以承受的剂量要求。因此,人们对其他抗菌药物治疗淋病进行了评估。1969年对2克氨苄青霉素(肌内注射)加1克丙磺舒进行了评估,治愈率达99%以上。还发现口服3.5克氨苄青霉素(7粒500毫克胶囊)和丙磺舒(2片500毫克片剂)是治疗淋病的有效方法。我们进行了本研究以评估一种新型单一口服联合疗法Polycillin - PRB的疗效。